APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bradykinin Receptor Antagonists

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bradykinin Receptor Antagonists Industry Growth and Trends Forecast to 2032

28 December 202599 pages

Choose your research edition.

Industry ResearchBradykinin Receptor Antagonists Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Bradykinin Receptor Antagonists Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Bradykinin Receptor Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bradykinin Receptor Antagonists Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Bradykinin Receptor Antagonists Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Bradykinin Receptor Antagonists market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bradykinin Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bradykinin Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bradykinin Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bradykinin Receptor Antagonists include Takeda Pharmaceuticals, Sandoz, Jiangsu Hengrui Pharmaceuticals, Chengdu Shengnuo Biology Pharmacy, Glenmark Pharmaceuticals, Fresenius Kabi, Eugia Pharma Specialities and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bradykinin Receptor Antagonists market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bradykinin Receptor Antagonists market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bradykinin Receptor Antagonists market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bradykinin Receptor Antagonists.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bradykinin Receptor Antagonists market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bradykinin Receptor Antagonists Market by Company

Takeda Pharmaceuticals

Sandoz

Jiangsu Hengrui Pharmaceuticals

Chengdu Shengnuo Biology Pharmacy

Glenmark Pharmaceuticals

Fresenius Kabi

Eugia Pharma Specialities

Cipla

Bradykinin Receptor Antagonists Segment by Type

Icatibant

Other

Bradykinin Receptor Antagonists Segment by Application

Hospital and Clinic

Pharmacy

Other

Bradykinin Receptor Antagonists Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bradykinin Receptor Antagonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bradykinin Receptor Antagonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bradykinin Receptor Antagonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bradykinin Receptor Antagonists manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bradykinin Receptor Antagonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Icatibant Table 2. Major Company of Other Table 3. Global Bradykinin Receptor Antagonists Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Bradykinin Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 5. Global Bradykinin Receptor Antagonists Sales Market Share in Volume by Type (2021-2026) Table 6. Global Bradykinin Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 7. Global Bradykinin Receptor Antagonists Sales Market Share in Value by Type (2021-2026) Table 8. Global Bradykinin Receptor Antagonists Price by Type (2021-2026) & (US$/Unit) Table 9. Global Bradykinin Receptor Antagonists Sales by Type (2027-2032) & (K Units) Table 10. Global Bradykinin Receptor Antagonists Sales Market Share in Volume by Type (2027-2032) Table 11. Global Bradykinin Receptor Antagonists Sales by Type (2027-2032) & (US$ Million) Table 12. Global Bradykinin Receptor Antagonists Sales Market Share in Value by Type (2027-2032) Table 13. Global Bradykinin Receptor Antagonists Price by Type (2027-2032) & (US$/Unit) Table 14. North America Bradykinin Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 15. North America Bradykinin Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Bradykinin Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 17. Europe Bradykinin Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Bradykinin Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Bradykinin Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Bradykinin Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 21. Latin America Bradykinin Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Bradykinin Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Bradykinin Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 24. Bradykinin Receptor Antagonists Industry Trends Table 25. Bradykinin Receptor Antagonists Industry Drivers Table 26. Bradykinin Receptor Antagonists Industry Opportunities and Challenges Table 27. Bradykinin Receptor Antagonists Industry Restraints Table 28. Global Bradykinin Receptor Antagonists Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Bradykinin Receptor Antagonists Revenue Market Share by Company (2021-2026) Table 30. Global Bradykinin Receptor Antagonists Sales by Company (2021-2026) & (K Units) Table 31. Global Bradykinin Receptor Antagonists Sales Share by Company (2021-2026) Table 32. Global Bradykinin Receptor Antagonists Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Bradykinin Receptor Antagonists Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Bradykinin Receptor Antagonists Major Company Production Sites and Headquarters Table 35. Global Bradykinin Receptor Antagonists Company, Product Type & Application Table 36. Global Bradykinin Receptor Antagonists Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Bradykinin Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Bradykinin Receptor Antagonists Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Bradykinin Receptor Antagonists Sales by Region (2021-2026) & (K Units) Table 41. Global Bradykinin Receptor Antagonists Sales Market Share in Volume by Region (2021-2026) Table 42. Global Bradykinin Receptor Antagonists Sales by Region (2021-2026) & (US$ Million) Table 43. Global Bradykinin Receptor Antagonists Sales Market Share in Value by Region (2021-2026) Table 44. Global Bradykinin Receptor Antagonists Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Bradykinin Receptor Antagonists Sales by Region (2027-2032) & (K Units) Table 46. Global Bradykinin Receptor Antagonists Sales Market Share in Volume by Region (2027-2032) Table 47. Global Bradykinin Receptor Antagonists Sales by Region (2027-2032) & (US$ Million) Table 48. Global Bradykinin Receptor Antagonists Sales Market Share in Value by Region (2027-2032) Table 49. Global Bradykinin Receptor Antagonists Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Bradykinin Receptor Antagonists Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Bradykinin Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 52. Global Bradykinin Receptor Antagonists Sales Market Share in Volume by Application (2021-2026) Table 53. Global Bradykinin Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 54. Global Bradykinin Receptor Antagonists Sales Market Share in Value by Application (2021-2026) Table 55. Global Bradykinin Receptor Antagonists Price by Application (2021-2026) & (US$/Unit) Table 56. Global Bradykinin Receptor Antagonists Sales by Application (2027-2032) & (K Units) Table 57. Global Bradykinin Receptor Antagonists Sales Market Share in Volume by Application (2027-2032) Table 58. Global Bradykinin Receptor Antagonists Sales by Application (2027-2032) & (US$ Million) Table 59. Global Bradykinin Receptor Antagonists Sales Market Share in Value by Application (2027-2032) Table 60. Global Bradykinin Receptor Antagonists Price by Application (2027-2032) & (US$/Unit) Table 61. North America Bradykinin Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 62. North America Bradykinin Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Bradykinin Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 64. Europe Bradykinin Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Bradykinin Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Bradykinin Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Bradykinin Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 68. Latin America Bradykinin Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Bradykinin Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Bradykinin Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Pharmaceuticals Company Information Table 72. Takeda Pharmaceuticals Business Overview Table 73. Takeda Pharmaceuticals Bradykinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Takeda Pharmaceuticals Bradykinin Receptor Antagonists Product Portfolio Table 75. Takeda Pharmaceuticals Recent Development Table 76. Sandoz Company Information Table 77. Sandoz Business Overview Table 78. Sandoz Bradykinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sandoz Bradykinin Receptor Antagonists Product Portfolio Table 80. Sandoz Recent Development Table 81. Jiangsu Hengrui Pharmaceuticals Company Information Table 82. Jiangsu Hengrui Pharmaceuticals Business Overview Table 83. Jiangsu Hengrui Pharmaceuticals Bradykinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Jiangsu Hengrui Pharmaceuticals Bradykinin Receptor Antagonists Product Portfolio Table 85. Jiangsu Hengrui Pharmaceuticals Recent Development Table 86. Chengdu Shengnuo Biology Pharmacy Company Information Table 87. Chengdu Shengnuo Biology Pharmacy Business Overview Table 88. Chengdu Shengnuo Biology Pharmacy Bradykinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Chengdu Shengnuo Biology Pharmacy Bradykinin Receptor Antagonists Product Portfolio Table 90. Chengdu Shengnuo Biology Pharmacy Recent Development Table 91. Glenmark Pharmaceuticals Company Information Table 92. Glenmark Pharmaceuticals Business Overview Table 93. Glenmark Pharmaceuticals Bradykinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Glenmark Pharmaceuticals Bradykinin Receptor Antagonists Product Portfolio Table 95. Glenmark Pharmaceuticals Recent Development Table 96. Fresenius Kabi Company Information Table 97. Fresenius Kabi Business Overview Table 98. Fresenius Kabi Bradykinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Fresenius Kabi Bradykinin Receptor Antagonists Product Portfolio Table 100. Fresenius Kabi Recent Development Table 101. Eugia Pharma Specialities Company Information Table 102. Eugia Pharma Specialities Business Overview Table 103. Eugia Pharma Specialities Bradykinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Eugia Pharma Specialities Bradykinin Receptor Antagonists Product Portfolio Table 105. Eugia Pharma Specialities Recent Development Table 106. Cipla Company Information Table 107. Cipla Business Overview Table 108. Cipla Bradykinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Cipla Bradykinin Receptor Antagonists Product Portfolio Table 110. Cipla Recent Development Table 111. North America Bradykinin Receptor Antagonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America Bradykinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 113. North America Bradykinin Receptor Antagonists Sales Market Share by Country (2021-2026) Table 114. North America Bradykinin Receptor Antagonists Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America Bradykinin Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 116. North America Bradykinin Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Bradykinin Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Bradykinin Receptor Antagonists Market Share by Country (2021-2026) Table 119. North America Bradykinin Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Bradykinin Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 121. Europe Bradykinin Receptor Antagonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe Bradykinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 123. Europe Bradykinin Receptor Antagonists Sales Market Share by Country (2021-2026) Table 124. Europe Bradykinin Receptor Antagonists Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe Bradykinin Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Bradykinin Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Bradykinin Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Bradykinin Receptor Antagonists Market Share by Country (2021-2026) Table 129. Europe Bradykinin Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Bradykinin Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Bradykinin Receptor Antagonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Bradykinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific Bradykinin Receptor Antagonists Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Bradykinin Receptor Antagonists Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific Bradykinin Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Bradykinin Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Bradykinin Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Bradykinin Receptor Antagonists Market Share by Country (2021-2026) Table 139. Asia-Pacific Bradykinin Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Bradykinin Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 141. Latin America Bradykinin Receptor Antagonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America Bradykinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 143. Latin America Bradykinin Receptor Antagonists Sales Market Share by Country (2021-2026) Table 144. Latin America Bradykinin Receptor Antagonists Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America Bradykinin Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Bradykinin Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Bradykinin Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Bradykinin Receptor Antagonists Market Share by Country (2021-2026) Table 149. Latin America Bradykinin Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Bradykinin Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Bradykinin Receptor Antagonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Bradykinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa Bradykinin Receptor Antagonists Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Bradykinin Receptor Antagonists Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Bradykinin Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Bradykinin Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Bradykinin Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Bradykinin Receptor Antagonists Market Share by Country (2021-2026) Table 159. Middle East and Africa Bradykinin Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Bradykinin Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Bradykinin Receptor Antagonists Distributors List Table 164. Bradykinin Receptor Antagonists Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Bradykinin Receptor Antagonists Image Figure 2. Global Bradykinin Receptor Antagonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bradykinin Receptor Antagonists Market Size (2021-2032) & (US$ Million) Figure 4. Global Bradykinin Receptor Antagonists Sales (2021-2032) & (K Units) Figure 5. Icatibant Image Figure 6. Global Icatibant Sales YoY Growth (2021-2032) & (K Units) Figure 7. Other Image Figure 8. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Bradykinin Receptor Antagonists Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Bradykinin Receptor Antagonists Market Share by Type 2025 VS 2032 Figure 11. North America Bradykinin Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 12. North America Bradykinin Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 13. Europe Bradykinin Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 14. Europe Bradykinin Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Bradykinin Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Bradykinin Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 17. Latin America Bradykinin Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Bradykinin Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Bradykinin Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Bradykinin Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Bradykinin Receptor Antagonists Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Bradykinin Receptor Antagonists Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Bradykinin Receptor Antagonists Market Share by Application 2025 VS 2032 Figure 31. North America Bradykinin Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 32. North America Bradykinin Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 33. Europe Bradykinin Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 34. Europe Bradykinin Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Bradykinin Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Bradykinin Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 37. Latin America Bradykinin Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Bradykinin Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Bradykinin Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Bradykinin Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 41. North America Bradykinin Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Bradykinin Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Bradykinin Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Bradykinin Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Bradykinin Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Bradykinin Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Bradykinin Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Bradykinin Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Bradykinin Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Bradykinin Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Bradykinin Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Bradykinin Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Bradykinin Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Bradykinin Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Bradykinin Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Bradykinin Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Bradykinin Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Bradykinin Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Bradykinin Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Bradykinin Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Bradykinin Receptor Antagonists Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Bradykinin Receptor Antagonists Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Icatibant
  • Other
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Takeda Pharmaceuticals
  • Sandoz
  • Jiangsu Hengrui Pharmaceuticals
  • Chengdu Shengnuo Biology Pharmacy
  • Glenmark Pharmaceuticals
  • Fresenius Kabi
  • Eugia Pharma Specialities
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bradykinin Receptor Antagonists Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bradykinin Receptor Antagonists Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bradykinin Receptor Antagonists Market by Type
  6. 1.3.1 Icatibant
  7. 1.3.2 Other
  8. 1.4 Global Bradykinin Receptor Antagonists Market Size by Type
  9. 1.4.1 Global Bradykinin Receptor Antagonists Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Bradykinin Receptor Antagonists Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Bradykinin Receptor Antagonists Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Bradykinin Receptor Antagonists Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Bradykinin Receptor Antagonists Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Bradykinin Receptor Antagonists Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Bradykinin Receptor Antagonists Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Bradykinin Receptor Antagonists Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bradykinin Receptor Antagonists Industry Trends
  2. 2.2 Bradykinin Receptor Antagonists Industry Drivers
  3. 2.3 Bradykinin Receptor Antagonists Industry Opportunities and Challenges
  4. 2.4 Bradykinin Receptor Antagonists Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bradykinin Receptor Antagonists Revenue (2021-2026)
  2. 3.2 Global Top Players by Bradykinin Receptor Antagonists Sales (2021-2026)
  3. 3.3 Global Top Players by Bradykinin Receptor Antagonists Price (2021-2026)
  4. 3.4 Global Bradykinin Receptor Antagonists Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bradykinin Receptor Antagonists Major Company Production Sites & Headquarters
  6. 3.6 Global Bradykinin Receptor Antagonists Company, Product Type & Application
  7. 3.7 Global Bradykinin Receptor Antagonists Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bradykinin Receptor Antagonists Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bradykinin Receptor Antagonists Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bradykinin Receptor Antagonists Tier 1, Tier 2, and Tier 3
4 Bradykinin Receptor Antagonists Regional Status and Outlook
  1. 4.1 Global Bradykinin Receptor Antagonists Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bradykinin Receptor Antagonists Historic Market Size by Region
  3. 4.2.1 Global Bradykinin Receptor Antagonists Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bradykinin Receptor Antagonists Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bradykinin Receptor Antagonists Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bradykinin Receptor Antagonists Forecasted Market Size by Region
  7. 4.3.1 Global Bradykinin Receptor Antagonists Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bradykinin Receptor Antagonists Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bradykinin Receptor Antagonists Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bradykinin Receptor Antagonists by Application
  1. 5.1 Bradykinin Receptor Antagonists Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Bradykinin Receptor Antagonists Market Size by Application
  6. 5.2.1 Global Bradykinin Receptor Antagonists Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Bradykinin Receptor Antagonists Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Bradykinin Receptor Antagonists Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Bradykinin Receptor Antagonists Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Bradykinin Receptor Antagonists Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Bradykinin Receptor Antagonists Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Bradykinin Receptor Antagonists Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Bradykinin Receptor Antagonists Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceuticals
  2. 6.1.1 Takeda Pharmaceuticals Company Information
  3. 6.1.2 Takeda Pharmaceuticals Business Overview
  4. 6.1.3 Takeda Pharmaceuticals Bradykinin Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceuticals Bradykinin Receptor Antagonists Product Portfolio
  6. 6.1.5 Takeda Pharmaceuticals Recent Developments
  7. 6.2 Sandoz
  8. 6.2.1 Sandoz Company Information
  9. 6.2.2 Sandoz Business Overview
  10. 6.2.3 Sandoz Bradykinin Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sandoz Bradykinin Receptor Antagonists Product Portfolio
  12. 6.2.5 Sandoz Recent Developments
  13. 6.3 Jiangsu Hengrui Pharmaceuticals
  14. 6.3.1 Jiangsu Hengrui Pharmaceuticals Company Information
  15. 6.3.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  16. 6.3.3 Jiangsu Hengrui Pharmaceuticals Bradykinin Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangsu Hengrui Pharmaceuticals Bradykinin Receptor Antagonists Product Portfolio
  18. 6.3.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  19. 6.4 Chengdu Shengnuo Biology Pharmacy
  20. 6.4.1 Chengdu Shengnuo Biology Pharmacy Company Information
  21. 6.4.2 Chengdu Shengnuo Biology Pharmacy Business Overview
  22. 6.4.3 Chengdu Shengnuo Biology Pharmacy Bradykinin Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Chengdu Shengnuo Biology Pharmacy Bradykinin Receptor Antagonists Product Portfolio
  24. 6.4.5 Chengdu Shengnuo Biology Pharmacy Recent Developments
  25. 6.5 Glenmark Pharmaceuticals
  26. 6.5.1 Glenmark Pharmaceuticals Company Information
  27. 6.5.2 Glenmark Pharmaceuticals Business Overview
  28. 6.5.3 Glenmark Pharmaceuticals Bradykinin Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Glenmark Pharmaceuticals Bradykinin Receptor Antagonists Product Portfolio
  30. 6.5.5 Glenmark Pharmaceuticals Recent Developments
  31. 6.6 Fresenius Kabi
  32. 6.6.1 Fresenius Kabi Company Information
  33. 6.6.2 Fresenius Kabi Business Overview
  34. 6.6.3 Fresenius Kabi Bradykinin Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Fresenius Kabi Bradykinin Receptor Antagonists Product Portfolio
  36. 6.6.5 Fresenius Kabi Recent Developments
  37. 6.7 Eugia Pharma Specialities
  38. 6.7.1 Eugia Pharma Specialities Company Information
  39. 6.7.2 Eugia Pharma Specialities Business Overview
  40. 6.7.3 Eugia Pharma Specialities Bradykinin Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Eugia Pharma Specialities Bradykinin Receptor Antagonists Product Portfolio
  42. 6.7.5 Eugia Pharma Specialities Recent Developments
  43. 6.8 Cipla
  44. 6.8.1 Cipla Company Information
  45. 6.8.2 Cipla Business Overview
  46. 6.8.3 Cipla Bradykinin Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Cipla Bradykinin Receptor Antagonists Product Portfolio
  48. 6.8.5 Cipla Recent Developments
7 North America by Country
  1. 7.1 North America Bradykinin Receptor Antagonists Sales by Country
  2. 7.1.1 North America Bradykinin Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bradykinin Receptor Antagonists Sales by Country (2021-2026)
  4. 7.1.3 North America Bradykinin Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bradykinin Receptor Antagonists Market Size by Country
  6. 7.2.1 North America Bradykinin Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bradykinin Receptor Antagonists Market Size by Country (2021-2026)
  8. 7.2.3 North America Bradykinin Receptor Antagonists Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bradykinin Receptor Antagonists Sales by Country
  2. 8.1.1 Europe Bradykinin Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bradykinin Receptor Antagonists Sales by Country (2021-2026)
  4. 8.1.3 Europe Bradykinin Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bradykinin Receptor Antagonists Market Size by Country
  6. 8.2.1 Europe Bradykinin Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bradykinin Receptor Antagonists Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bradykinin Receptor Antagonists Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bradykinin Receptor Antagonists Sales by Country
  2. 9.1.1 Asia-Pacific Bradykinin Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bradykinin Receptor Antagonists Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bradykinin Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bradykinin Receptor Antagonists Market Size by Country
  6. 9.2.1 Asia-Pacific Bradykinin Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bradykinin Receptor Antagonists Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bradykinin Receptor Antagonists Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bradykinin Receptor Antagonists Sales by Country
  2. 10.1.1 South America Bradykinin Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bradykinin Receptor Antagonists Sales by Country (2021-2026)
  4. 10.1.3 South America Bradykinin Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bradykinin Receptor Antagonists Market Size by Country
  6. 10.2.1 South America Bradykinin Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bradykinin Receptor Antagonists Market Size by Country (2021-2026)
  8. 10.2.3 South America Bradykinin Receptor Antagonists Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bradykinin Receptor Antagonists Sales by Country
  2. 11.1.1 Middle East and Africa Bradykinin Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bradykinin Receptor Antagonists Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bradykinin Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bradykinin Receptor Antagonists Market Size by Country
  6. 11.2.1 Middle East and Africa Bradykinin Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bradykinin Receptor Antagonists Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bradykinin Receptor Antagonists Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bradykinin Receptor Antagonists Value Chain Analysis
  2. 12.1.1 Bradykinin Receptor Antagonists Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bradykinin Receptor Antagonists Production Mode & Process
  7. 12.2 Bradykinin Receptor Antagonists Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bradykinin Receptor Antagonists Distributors
  10. 12.2.3 Bradykinin Receptor Antagonists Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst